Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2101556

C1=Cc2nc1c(-c1ccncc1)c1ccc([nH]1)c(-c1ccncc1)c1nc(c(-c3ccncc3)c3ccc([nH]3)c2-c2ccncc2)C=C1.[Cl-].[Cl-].[Mn+2]

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 4/20 0.76
▸ TERT O14746 4/20 0.57
▸ CYCS P99999 3/20 0.54
▸ ENPP2 Q13822 1/20 0.53
▸ ABCG2 Q9UNQ0 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31627581 1.00 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
SCHEMBL245937 0.98 TOP1 (0.78) TOP1TERTCYCSENPP2ABCG2
SCHEMBL29961137 0.98 TOP1 (0.78) TOP1TERTCYCSENPP2ABCG2
SCHEMBL31315103 0.96 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
SCHEMBL31313616 0.96 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
SCHEMBL31313985 0.96 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
Magnesium SCHEMBL31258521 0.96 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
SCHEMBL600975 0.96 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
SCHEMBL2423633 0.96 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
SCHEMBL31313917 0.96 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7699964-B2 Composed of polymeric material containing superoxide dismutase and /or catalase; enhanced biosensor integrity and performance; accurate transcutaneous glucose monitoring ABBOTT DIABETES CARE INC. (US) 2010-04-20 — — US claimed
EP-1721149-A1 ANALYTE SENSOR, AND ASSOCIATED SYSTEM AND METHOD EMPLOYING A CATALYTIC AGENT Therasense, Inc. (US) 2006-11-15 — — EP claimed
WO-2005078424-A1 ANALYTE SENSOR, AND ASSOCIATED SYSTEM AND METHOD EMPLOYING A CATALYTIC AGENT THERASENSE INC. (US) 2005-08-25 — — WO claimed
US-20050173245-A1 Composed of polymeric material containing superoxide dismutase and /or catalase; enhanced biosensor integrity and performance; accurate transcutaneous glucose monitoring ABBOTT DIABETES CARE INC. 2005-08-11 — — US claimed
WO-2025137203-A1 GLUCOSE OXIDASE SENSORS WITH IMPROVED STABILITY ABBOTT DIABETES CARE, INC. (US) 2025-06-26 — — WO disclosed
US-20250194964-A1 GLUCOSE OXIDASE SENSORS WITH IMPROVED STABILITY ABBOTT DIABETES CARE, INC. 2025-06-19 — — US disclosed
US-8761857-B2 Analyte sensor, and associated system and method employing a catalytic agent ABBOTT DIABETES CARE INC. (US) 2014-06-24 — — US disclosed
US-8444834-B2 Redox polymers for use in analyte monitoring ABBOTT DIABETES CARE INC. (US) 2013-05-21 — — US disclosed
US-20130006079-A1 Analyte Sensor, and Associated System and Method Employing a Catalytic Agent ABBOTT DIABETES CARE INC. 2013-01-03 — — US disclosed
US-20120132525-A1 REDOX POLYMERS FOR USE IN ANALYTE MONITORING ABBOTT DIABETES CARE INC. 2012-05-31 — — US disclosed
US-8165651-B2 Analyte sensor, and associated system and method employing a catalytic agent ABBOTT DIABETES CARE INC. (US) 2012-04-24 — — US disclosed
US-7699964-B2 Composed of polymeric material containing superoxide dismutase and /or catalase; enhanced biosensor integrity and performance; accurate transcutaneous glucose monitoring ABBOTT DIABETES CARE INC. (US) 2010-04-20 — — US disclosed
US-20070191701-A1 Analyte Sensor, and Associated System and Method Employing a Catalytic Agent ABBOTT DIABETES CARE, INC. (US) 2007-08-16 — — US disclosed
EP-1721149-A1 ANALYTE SENSOR, AND ASSOCIATED SYSTEM AND METHOD EMPLOYING A CATALYTIC AGENT Therasense, Inc. (US) 2006-11-15 — — EP disclosed
US-20050215871-A1 Analyte sensor, and associated system and method employing a catalytic agent ABBOTT DIABETES CARE INC. 2005-09-29 — — US disclosed
WO-2005078424-A1 ANALYTE SENSOR, AND ASSOCIATED SYSTEM AND METHOD EMPLOYING A CATALYTIC AGENT THERASENSE INC. (US) 2005-08-25 — — WO disclosed
US-20050173245-A1 Composed of polymeric material containing superoxide dismutase and /or catalase; enhanced biosensor integrity and performance; accurate transcutaneous glucose monitoring ABBOTT DIABETES CARE INC. 2005-08-11 — — US disclosed
Send feedback